猪细胞周期蛋白依赖性激酶2多克隆抗体的制备与鉴定

为研究猪细胞周期蛋白依赖性激酶2(pCDK2)的生物学功能,本试验构建重组原核表达载体pET28a-pCdk2,转化大肠杆菌BL21 (DE3)受体菌,用IPTG诱导重组蛋白(rpCDK2)表达并进行SDS-PAGE和Western blotting鉴定,蛋白经纯化及与弗氏佐剂乳化后免疫家兔制备多克隆抗体。分别用Western blotting和免疫过氧化物酶单层细胞染色法(IPMA)检测抗体的免疫活性。结果显示,成功表达了rpCDK2蛋白,该蛋白以可溶性和包涵体两种形式存在,可溶性rpCDK2蛋白分子质量约为38 ku,包涵体rpCDK2蛋白在38~43 ku间有3种不同分子质量形式;IPMA检测结果显示,所制备的pCDK2蛋白多克隆抗体与猪肾细胞(PK-15)和猪睾丸细胞(ST)免疫染色呈特异性反应,且Western blotting分析显示,多克隆抗体与这两种细胞的总蛋白反应出现4条特异性条带(分子质量在34~50 ku之间),可能跟pCDK2的多种磷酸化形式有关。本试验利用原核表达系统成功制备了rpCDK2蛋白,并制备了免疫活性和特异性良好的pCDK2蛋白多克隆抗体,为该蛋白生物学功能及相关疾病研究提供了基础材料。     

猪腺病毒3型Hexon蛋白多克隆抗体制备与免疫活性鉴定

本研究旨在制备猪腺病毒3型(PADV-3)Hexon蛋白多克隆抗体.试验构建重组原核表达载体pET28a-Hexon,IPTG诱导重组蛋白的表达并进行Western blotting鉴定,目的蛋白与佐剂混合、乳化制备免疫原,免疫家兔制备Hexon蛋白多克隆抗体.采用免疫过氧化物酶单层细胞染色法(IPMA)检测抗体的免疫活性与抗体滴度.结果显示,Hexon蛋白原核表达以包涵体形式存在,分子质量约为105 ku;真核细胞表达的Hexon蛋白均定位于HEK293细胞质内,细胞核内无分布;IPMA测定所制备的多克隆抗体滴度为1:1 600,该抗体与体外培养的PADV-3及稳定表达Hexon蛋白的细胞均呈特异性反应.结果表明本试验制备的PADV-3型Hexon蛋白多克隆抗体免疫活性和特异性良好.     

猪IL-2和IL-6的原核表达及多克隆抗体的制备

IL-2和IL-6是机体重要的免疫调节因子,在佐剂的应用方面具有很好的发展前景。论文以pTIL-2和pTIL-6为模板进行PCR扩增得到猪白细胞介素2(pIL-2)和猪白细胞介素6(pIL-6)的全基因序列,通过EcoRⅠ和HindⅢ双酶切及连接反应将目的基因亚克隆到原核表达载体pET30a中构建了融合表达质粒pETIL-2和pETIL-6。将重组质粒分别转化大肠埃希菌BL21(DE3)和Rosetta(DE3),37℃在IPTG诱导下高效表达了pIL-2和pIL-6,分子质量分别约为26ku和30ku。将包涵体纯化并复性后免疫家兔,制备的兔抗pIL-2和pIL-6的多克隆抗体经ELISA检测效价在1∶12800以上。     

人PrP多克隆抗体的制备及鉴定

制备PrP(prion protein)多克隆抗体,验证原核表达的人PrP的抗原性,为PrP空间构象的转变机制等深层次的研究以及人PrP单克隆抗体的制备提供重要的试验材料.以融合的人成熟PrP蛋白(mature prion protein,mPrP)为抗原,以pET30a(+)空载体的E.coli BL21 (DE3)的菌体蛋白作为对照免疫原,免疫小鼠.ELISA和Western blot分别检测多克隆抗体的效价和特异性.结果5只动物中3只均产生了较高效价的抗血清,确定人 PrP多克隆抗体效价为1∶4 096,能与人mPrP特异性结合.证明获得的人mPrP具有良好的免疫原性.     

猪SIgA分泌片的分离纯化及其多克隆抗体的制备

为制备抗分泌片多克隆抗体,采用分子筛凝胶层析、离子交换层析和硫酸铵盐析法从猪初乳中分离纯化分泌片和SIgA。SDS—PAGE鉴定表明,纯化的SIgA呈现分泌片、重链和轻链三条带,大小约为70ku;凝胶薄层扫描分析SIgA和分泌片纯度分别为90％和89％;琼脂扩散鉴定表明,SIgA和分泌片与抗分泌片单克隆抗体发生了特异反应。以纯化分泌片为抗原,制备抗分泌片多克隆抗体,琼脂扩散检测多抗的效价为1：32。高纯度分泌片的提取及高效价抗分泌片多抗的制备为粘膜负．疫研究奠定了物质基础。     

猪圆环病毒2b型Cap蛋白多克隆抗体制备及其生物学特性分析

为了使猪圆环病毒2b型(PCV2b)Cap蛋白在猪圆环病毒病等疾病的诊断和防制方面取得更有效的应用,本试验将编码PCV2b Cap蛋白的ORF2基因克隆到原核表达载体pET-32a(+)中,并构建pET-32a-ORF2重组质粒,重组质粒转化大肠杆菌BL21受体菌后,通过IPTG诱导表达重组蛋白,将重组蛋白用镍柱进行纯化并免疫大白兔,制备兔抗PCV2b Cap蛋白的多克隆抗体。利用ELISA、Western blotting、间接免疫荧光及病毒交叉反应等试验对制备的多克隆抗体进行生物学特性检测。ELISA检测结果显示,该抗体效价可达到1:2¹⁶;Western blotting检测结果显示,该多克隆抗体可与PCV2b产生特异性的反应条带,说明其具有较好的反应活性;间接免疫荧光试验结果显示,该多克隆抗体能识别感染PK-15细胞中的PCV2b,说明该多克隆抗体具有鉴别诊断PCV2b的能力;病毒交叉试验结果显示,该多克隆抗体能与PCV2b反应,而不与猪流行性腹泻病毒(PEDV)、猪传染性胃肠炎病毒(TGEV)、猪繁殖与呼吸综合征病毒(PRRSV)、猪轮状病毒(PRoV)、猪伪狂犬病病毒(PRV)、猪细小病毒(PPV)等猪源病毒发生交叉反应,表明该多克隆抗体具有高度特异性。本试验制备的抗PCV2b Cap蛋白多克隆抗体为PCV2b病原特性研究及该病的临床检测奠定基础。     

Preparation of Polyclonal Antibody against Porcine Circovirus Type 2b Cap Protein and Analysis of its Biological Characteristics

In order to build more effective use of porcine circovirus type 2b (PCV2b) Cap protein on the diagnosis and control of diseases like porcine circovirus disease, the ORF2 gene which encoding porcine circovirus type 2b Cap protein was cloned into the prokaryotic expression vector pET-32a (+), constructing a recombinant plasmid pET-32a-ORF2, then the recombinant plasmid was transformed into E.coli BL21 and induced by IPTG to express recombinant protein, the recombinant protein was purified with nickel column.Then polyclonal antibody (PcAb) was prepared by immunization of rabbit with purified protein.ELISA, Western blotting, indirect immunofluorescence assay and the specificity experiments were used to detect the biological characteristics of the polyclonal antibody.The titer of polyclonal antibody was about 1:2¹⁶ detected by ELISA.Western blotting result confirmed that polyclonal antibody could react with PCV2b specially.Indirect immunofluorescence assay showed that polyclonal antibody was able to detect PCV2b in PK-15 cells, this result suggested that the polyclonal antibody had the ability to differential diagnosis of PCV2b.The specificity experiment showed that the polyclonal antibody only reacted with PCV2b, and did not react with PEDV, TGEV, PRRSV, PRoV, PRV and PPV.The polyclonal antibody against PCV2b prepared in this study provided a powerful tool for the study of etiological characteristics and clinic diagnosis of this disease.     

猪细小病毒VP2的原核表达与多克隆抗体制备

克隆猪细小病毒(PPV)VP2基因全长1 740bp,构建其原核表达载体后进行蛋白的表达与纯化,接种家兔制备多克隆抗体。用PCR方法扩增PPV VP2全长基因,扩增产物克隆至表达载体pET-32a并转化至E.coli BL21(DE3)感受态中。分别用不同诱导时间、IPTG浓度、温度诱导表达VP2重组蛋白,经SDS-PAGE电泳切胶回收纯化目的蛋白。对家兔进行3次免疫后,采集血清制备抗体。PCR扩增得到1 740bp的VP2基因片段;构建原核表达载体pET-32a-VP2,经37℃,IPTG浓度1.0mmol/L诱导表达4h可得分子质量大小约为82ku目的蛋白;间接ELISA检测抗体效价可达1∶12 800;Western blot证明所制备的抗体能够有效的应用于PPV VP2抗原的检测。本研究成功构建了表达PPV VP2基因的原核载体,获得了VP2蛋白,制备了兔抗多克隆抗体,为建立检测PPV VP2蛋白ELISA方法奠定了基础。     

鸭抗菌肽Dcath多克隆抗体的制备及鉴定

为制备效价高、特异性强的鸭抗菌肽Dcath多克隆抗体,并对制备的多克隆抗体进行鉴定和初步应用,采用Fmoc固相化学合成法合成鸭抗菌肽Dcath的成熟肽段,与血蓝蛋白偶联后,与弗氏完全佐剂乳化,按照免疫程序免疫接种大白兔,采集免疫兔血清,亲和层析纯化多抗,ELISA检测多抗效价,以制备的多抗为一抗,用Western blot检测鸭血外周异嗜性粒细胞中Dcath的表达,用免疫组化(IHC)检测鸭回肠、肾脏组织中Dcath的表达。结果显示,合成的鸭抗菌肽Dcath纯度达98.28%,经ELISA检测,纯化的兔多抗效价达到1∶128000,经Western blot检测,鸭血外周异嗜性粒细胞大量表达Dcath,经免疫组化检测,鸭Dcath在肾脏及回肠组织细胞中广泛表达。结果表明,成功制备了鸭抗菌肽Dcath多克隆抗体,效价高、特异性强,为深入研究鸭抗菌肽Dcath的生物学特性提供了技术支持。     

猪NLRP6蛋白的原核表达、纯化及其多克隆抗体的制备

试验旨在表达、纯化猪NLRP6蛋白,并制备鼠抗NLRP6多克隆抗体。根据猪NLRP6全基因核苷酸序列（GenBank登录号：XM_003124236.4）设计特异性引物,利用PCR方法从pMD-19T-NLRP6重组载体中扩增NLRP6基因片段,将扩增产物与原核表达载体pET-32a（+）连接,获得重组质粒pET-32a-NLRP6,经抗性筛选阳性菌、双酶切鉴定、PCR及测序分析后,将其转化大肠杆菌Rosetta（DE3）感受态细胞中,并进行IPTG诱导表达及Western blotting鉴定。对获得的重组融合蛋白进行可溶性分析,经变性、镍柱亲和纯化、复性后得到纯化的融合蛋白,将其免疫BALB/c小鼠制备多克隆抗体。结果显示,试验成功克隆大小约为576 bp的NLRP6基因序列,经鉴定重组质粒pET-32a-NLRP6构建正确,通过IPTG诱导获得大小约34 ku的NLRP6重组融合蛋白,Western blotting分析表明其与小鼠抗6×His单克隆抗体呈阳性反应。可溶性分析结果显示,NLRP6重组融合蛋白以包涵体形式存在,约占95%。纯化的NLRP6重组融合蛋白免疫BALB/c小鼠获得多克隆抗体,经Western blotting分析显示出特异性反应。本试验成功制备了具有免疫原性的NLRP6蛋白及其鼠源多克隆抗体,为NLRP6蛋白生物学功能及相关疾病致病机制研究提供了基础材料。     

Preparation,Identification and Purification of Polyclonal Antibody against STa

Enterotoxic Escherichia coli (ETEC) can cause acute diarrhea in human and animals, and its key virulent factor is heat-stable enterotoxin (ST).ST is a peptide with small molecular weight and great toxicity but without immunogenicity, so how to keep its immunogenicity and reduce its toxicity has become a hot research topic for preparing ST toxoid vaccine.In this study, rabbit serum albumin (RSA) was purified by rivanol method and activated in 0.2% glutaraldehyde solution before RSA was conjugated to synthetic methanol-soluble STa, SDS-PAGE result showed that an approximate 108.5 ku complete antigen was obtained.New Zealand White rabbits were immunized with the conjugate four times, the serum was then collected and used to purify immunoglobulin by immunoprecipitation with Protein A/G Plus-Agarose.Dot-ELISA and Western blotting result showed that the titer of the antiserum both reached 1:400.These results indicated that anti-STa polyclonal antibody was successfully prepared, which provided the way for screening of ST structure analogues.     

抗STa多克隆抗体的制备、鉴定和纯化

产肠毒素大肠杆菌(ETEC)可引起人及动物急性腹泻,其关键毒力因子为耐热肠毒素(ST)。由于ST是一种具有强烈毒性但缺乏免疫原性的小分子肽,如何在保持其免疫原性的同时减弱其毒性已成为制备ST类毒素疫苗的研究热点。本试验以利凡诺法提纯兔血清白蛋白(RSA),经0.2%戊二醛活化,再与人工合成的甲醇可溶性STa偶联,十二烷基硫酸钠—聚丙烯酰胺凝胶电泳(SDS-PAGE)结果显示获得分子质量约108.5 ku的完全抗原。用该偶联物免疫新西兰白兔4次,采集抗血清并用Protein A/G 琼脂糖小珠进行纯化,斑点酶联免疫吸附试验(dot-ELISA)和免疫印迹(Western blotting)结果显示抗血清效价均为1:400。试验结果表明抗STa多克隆抗体成功制备,这为筛选ST结构类似物做有益的铺垫。     

猪圆环病毒2型Cap蛋白单克隆抗体的制备

本研究利用已构建的基因工程重组菌表达猪圆环病毒2型(porcine circovirus type 2,PCV2)ORF2编码的Cap蛋白,纯化后作为免疫原,免疫8周龄BALB/c小鼠,取其脾细胞与SP2/0骨髓瘤细胞融合。经间接免疫荧光试验(IFA)筛选及有限稀释法进行3次亚克隆后,本试验最终获得5株稳定分泌抗PCV2 Cap蛋白单克隆抗体的杂交瘤细胞,分别命名为3D12、4D5、4B9、4C9和4G10。其中4D5为IgG2b亚型,其余4株单克隆抗体均为IgG1亚型,轻链类型均为κ。Western blotting鉴定结果表明获得的5株单克隆抗体均不能特异性的识别47 ku重组PCV2 Cap蛋白;对病毒感染细胞进行IFA试验,结果显示5株单克隆抗体均特异性的识别病毒抗原,表明5株单克隆抗体识别的抗原表位均为构象表位。中和试验结果表明,5株单克隆抗体均有中和活性。本试验结果为进一步探索ORF2基因的结构、功能及建立快速准确的诊断方法奠定了基础。     

Preparation of Monoclonal Antibodies against Porcine Circovirus Type 2 Cap Protein

The structural protein Cap encoded by ORF2 of porcine circovirus type 2 (PCV2) was expressed in genetic engineering recombinant bacteria and used as the immunogen after purification.Five hybridoma cell lines against PCV2 Cap protein named as 3D12,4D5,4B9,4C9 and 4G10,respectively,were developed after fusion between SP2/0 myeloma cells and spleen cells of BALB/c mice immunized with purified recombinant PCV2 Cap protein.Except the heavy chain type of 4D5 was identified as IgG2b,others were identified as IgG1;The light chains were all kappa.In Western blotting assay,all the monoclonal antibodies (mAbs) couldn't specifically recognize the 47 ku recombinant PCV2 Cap protein,but showed strong specific fluorescence in PCV2 infected PK15 cells in IFA,which indicated that all the mAbs recognized comformational epitope.The neutralization test showed that all the mAbs had neutralization activity.These results laid the foundation for further study of the structure and function of PCV2 ORF2 gene,and establishment of the method for diagnosing PCV2 rapidly and exactly.     

Preparation and Identification of Canine Parvovirus NY Strain VP2 Protein Polyclonal Antibody

This study was aimed to prepare canine parvovirus (CPV) VP2 protein polyclonal antibody.The recombinant expression vector pET28a-CPV-VP2 was constructed and transfromed into E.coli BL21 (DE3),the expression of recombinant proteins was induced by IPTG from which the fusion protein was identified by SDS-PAGE.The target protein was purified and emulsify with adjuvant,the prepared immunogen was inoculated into rabbit by subcutaneous injections to prepare of VP2 protein specific polyclonal antibody.The immuno-activity,titers,neutralization titers of the prepared polyclonal antibody were determined by immunoperoxidase monolayer assay (IPMA).The results showed that the expressed recombinant protein VP2 (rVP2) existed in the form of inclusion body with a molecular weight of 72 ku.The prepared polyclonal antibody titer was 1 600 dilution,the virus titer was 10⁷ TCID₅₀/mL,the neutralizing titer was 1∶2 884.The antibodies showed specific reaction with CPV.In conclusion,rVP2 specific polyclonal antibody showed wonderful immunocompetence,specificity and neutralizing activity,providing foundation for the development of genetic vaccine and clinical therapeutic method.     

Preparation of Polyclonal Antibodies against Swine Pseudorabies Virus and Study on the Immunological Activity

This study was aimed to obtain polyclonal antibody against swine pseudorabies virus (PRV) Min A strain,and provide a theoretical basis for the study of the treatment and detection of PRV.This study was performed on PK-15 cell and proliferation of PRV was measured as TCID₅₀ 10^-7.372,the protein concentration of PRV was measured as 3.6 mg/mL.Choosing five healthy male rabbits (2.5 kg±0.2 kg) as experimental animals and using PRV obtained as the antigen,we got polyclonal antibody against PRV.Antiserum titer was 1:32 000,antigen coating dilution was 1:40,the best coating conditions was 4 ℃ 12 h,the best blocking time was 1 h,the best working dilution of enzyme labled antibody was 1:8 000,the result of cell lesions neutralization test showed that PRV antiserum prepared in this assay at 1:16 dilution could protect 50% of PK-15 cells from being infected by PRV,and negative serum couldn't protect PK-15 cells from being infected by PRV.The study successfully prepared polyclonal antibodies against PRV.     

犬细小病毒NY株VP2蛋白多克隆抗体的制备与鉴定

试验旨在制备犬细小病毒（canine parvovirus,CPV）VP2蛋白多克隆抗体。构建pET28a-CPV-VP2重组表达质粒转化大肠杆菌BL21（DE3）感受态细胞,经IPTG诱导,SDS-PAGE鉴定融合蛋白的表达,纯化目的蛋白与佐剂混合、乳化制备后作为免疫原,免疫家兔制备VP2蛋白多克隆抗体;采用免疫过氧化物酶单层细胞染色法（immunoperoxidase monolayer assay,IPMA）检测抗体的免疫活性、抗体滴度、病毒滴度及中和活性。结果表明,重组VP2蛋白（rVP2）以包涵体形式存在,分子质量约为72 ku;所制备的多克隆抗体滴度为1 600倍,病毒滴度为10⁷ TCID₅₀ /mL,中和效价为1∶2 884,该抗体与体外培养的CPV呈特异性反应,CPV VP2蛋白的多克隆抗体免疫活性和特异性良好,且中和活性高,为CPV基因工程疫苗的研究和临床治疗奠定了基础。     

猪伪狂犬病病毒多克隆抗体的制备及免疫学活性研究

本研究旨在获得抗猪伪狂犬病病毒(PRV)闽A株的多克隆抗体,为PRV的治疗与检测提供理论基础.本研究在PK-15细胞上进行PRV的增殖,测定其TCID₅₀为10^-7.372,粗提蛋白后,测定PRV蛋白浓度为3.6 mg/mL.试验选用25只健康、雄性、体重为2.5 kg±0.2 kg的新西兰大白兔为试验动物,用获得的PRV为抗原免疫后,获得抗PRV多克隆抗体.测定其抗血清效价为1:32 000,抗原包被稀释度为1:40,最佳包被条件为4 ℃ 12 h,最佳封闭时间为1 h,酶标二抗最佳工作稀释度为1:8 000.细胞病变中和试验结果表明,本研究制备的PRV抗血清在1:16的稀释情况下能保护50%的PK-15细胞免受PRV的攻击,而阴性血清不能保护PK-15细胞免受PRV的感染.结果表明本研究成功制备了PRV多克隆抗体.     

抗柱状黄杆菌多克隆抗体的制备及其免疫学特性鉴定

为制备抗柱状黄杆菌多克隆抗体,本研究利用颗粒性抗原免疫新西兰白兔,收集的抗血清通过辛酸-硫酸铵法纯化,采用间接ELISA法检测纯化后多克隆抗体的效价和交叉反应性。结果显示,制备的多克隆抗体蛋白质浓度为29.28 mg/mL,效价在1:6.4×10⁴以上,与迟钝爱德华氏菌、大肠杆菌、嗜水气单胞菌、鳗弧菌、溶藻弧菌、副溶血弧菌及哈维氏弧菌等水生动物致病菌均无交叉反应。本研究成功建立了抗柱状黄杆菌多克隆抗体的制备方法,可用于柱状黄杆菌的快速检测。     

猪磷酸酪氨酸互作结构域1基因的融合表达及其多克隆抗体的制备和鉴定

本文旨在通过原核表达获得猪磷酸酪氨酸互作结构域1(p PID1)重组蛋白,并制备p PID1多克隆抗体。将p PID1基因插入p ET28a(+),构建重组p ET28a(+)-p PID1大肠杆菌表达质粒,然后将重组质粒p ET28a(+)-p PID1转化到大肠杆菌BL21感受态细胞中,获得的重组子以不同异丙基硫代-β-D-半乳糖苷(IPTG)浓度、温度和时间诱导,确定p PID1融合蛋白表达的最适条件。将表达产物经镍离子-亚氨基二乙酸(Ni2+-IDA)亲和层析纯化后进行基质辅助激光解析电离飞行时间质谱(MALDI-TOF-MSMS)鉴定。同时,将纯化获得的p PID1融合蛋白免疫SD大鼠,制备p PID1多克隆抗体,并检测抗体效价。结果表明:p PID1融合蛋白表达的最佳条件为30℃以0.1 mmol/L IPTG诱导4 h;纯化的融合蛋白经MALDI-TOF-MSMS鉴定为p PID1;特异性的p PID1多克隆抗体成功制备,抗体效价为1∶20 480。本试验成功制备了高纯度的重组p PID1及其多克隆抗体。